To feed the world in a healthy, sustainable way, nations need to reorient today’s agri-food systems for distant generations, said Chris Barrett at an Earth Day forum.
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
The grant will fund an effort to study how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson’s disease.
Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine, has been elected to the National Academy of Medicine
The 2020 nationwide lockdown India imposed in response to the COVID-19 pandemic caused disruptions that negatively impacted women’s nutrition, according to a new study from the Tata-Cornell Institute for Agriculture and Nutrition.
The Michigan city’s adult residents suffered a range of adverse health symptoms potentially linked to the water crisis that began in 2014, with Black residents affected disproportionately, according to new research.
In a study published April 14 in PLOS One, an international research team including Michèle Belot, professor in the Department of Economics, found that children valued sweet food more after receiving it as a reward.
Renerva, a medical startup developing an injectable gel to speed the healing of damaged nerves and creating a nerve-graft product, has joined Cornell’s McGovern Center.
The genetic changes that underlie an especially lethal type of prostate cancer, called neuroendocrine prostate cancer, have been revealed in a new study at Weill Cornell Medicine. Learning more about what causes this type of cancer could lead to new approaches for treating it.
Cornell researchers are leading a review on the risk of coronavirus transmission through breast milk intake and breastfeeding, to inform WHO guidelines during the pandemic.